Events
News
Donate
Contact

Open search modal

X
LinkedIn

About
Funding
Who We Help
Programs
Resources
Impact
Start Your Journey

About
Funding
Who We Help
Programs
Resources
Impact
Start Your Journey

Commercialization Institute

Commercialization Institute Application

Δ

1Contact Information

2Entity Information

3Registration & Entity Status

4SBIR/STTR Project Background & Information

5Project Status & Readiness

6Commercialization Progress

7Final Steps

Contact Information

You may complete or view different parts of the form by selecting the title or number above. You may also utilize "Save and Continue Later" at the bottom of form.
For this section, please tell us about yourself and your background.

Name(Required)

First Last

Title(Required)

Email(Required)

Phone Number(Required)

Phone Type

Contact Demographic Status(Required)

Select all that apply

Veteran

Woman

BIPOC

Disabled

Rural

None of the above

Do not wish to answer

Entity Information

Legal Company Name(Required)

DBA

Company Physical Address(Required)

Street Address Address Line 2 City State ZIP Code

Which Minnesota county is the company located?(Required)

Company Website

Company LinkedIn Profile (Optional)

Provide a summary description of your company.(Required)

Alternative wording: Please provide a company description for use in public communications such as our website, social media, or printed materials.

Registration & Entity Status

Unique Entity Identification (UEI)

Date of Incorporation(Required)

MM slash DD slash YYYY

Is the company a startup from the University of Minnesota, the Mayo Clinic, or another institution?(Required)

Yes

No

Which institution?

Number of Full-Time Employees(Required)

Number of Part-Time Employees(Required)

Number of Independent Contractors/Consultants(Required)

Name of Owner(Required)

First Last

Owner Title

Owner Phone Number

Email(Required)

51% Owner(s) Demographic Status(Required)

The share of 51% or more may be met individually, or be combined across owners. Please check all that apply.

Veteran

Woman

BIPOC

None of the above

Do not wish to answer

What is the company's state senate legislative district?(Required)

What is the company's state representative legislative district?(Required)

What is the company's congressional district?(Required)

4.2.a Background SBIR/STTR Project Information

Each applicant must provide a concise narrative describing the technical foundation and current commercialization status of the SBIR/STTR-funded project.

This field is hidden when viewing the form

Project Category(Required)

This field is hidden when viewing the form

Which Advanced Manufacturing sub-category matches your project closest?

This field is hidden when viewing the form

Which Agriculture and Food Systems sub-category matches your project closest?

This field is hidden when viewing the form

Which Aerospace and Space Technologies sub-category matches your project closest?

Which Artificial Intelligence and Machine Learning sub-category matches your project closest?

This field is hidden when viewing the form

Which Clean Energy and Sustainability sub-category matches your project closest?

This field is hidden when viewing the form

Which Climate and Environmental Sciences sub-category matches your project closest?

This field is hidden when viewing the form

Which Cybersecurity and Information Assurance sub-category matches your project closest?

This field is hidden when viewing the form

Which Defense and National Security Technologies sub-category matches your project closest?

This field is hidden when viewing the form

Which Education and Workforce Development Technologies sub-category matches your project closest?

This field is hidden when viewing the form

Which Health and Biomedical Technology sub-category matches your project closest?

This field is hidden when viewing the form

Which Transportation and Mobility sub-category matches your project closest?

This field is hidden when viewing the form

Which Quantum Science and Engineering sub-category matches your project closest?

SBIR/STTR Project Title(Required)

Grant/Contract Number(Required)

Which Federal Agency funded your SBIR/STTR award?(Required)

Department of Health and Human Services (NIH, FDA, CDC, ACL, ARPA-H)

National Science Foundation

Department of War (Army, Navy, Air Force, Marine Corps, DARPA, etc.)

Department of Energy

Department of Homeland Security

Department of Commerce

Department of Transportation

Environmental Protection Agency

Department of Agriculture

National Aeronautics and Space Administration

Other

Which HHS Institute or Center?

Which DoW component?

Which DOC sub-agency?

Which program was the project awarded under?(Required)

Wording change?

SBIR

STTR

Other

Which phase was project awarded under?(Required)

Phase I

Phase II

Fast Track

SBIR Direct to Phase II

Phase IIB

Other

Period of Performance Start Date:(Required)

MM slash DD slash YYYY

Period of Performance End Date:(Required)

MM slash DD slash YYYY

Government Program Contact Name(Required)

First Last

Government Program Contact Name Email(Required)

Government Program Contact Name Phone

Was the SBIR/STTR project a clinical trial?

Yes

No

Did the proposed project involve an industry partner, academic institution(s), a federal laboratory, or another institution?(Required)

Yes

No

Intellectual Property Status(Required)

Patents Filed

Patents Issued

Patents Licensed

Trade Secret

None

4.2.b Background SBIR/STTR Project Information

Each applicant must provide a concise narrative describing the technical foundation and current commercialization status of the SBIR/STTR-funded project.

Project Overview (1000 characters)(Required)

Provide a concise overview of the SBIR/STTR project, including its original objectives, major technical achievements, and key outcomes.

Project Description(Required)

Provide a clear description of the product or service enabled by the innovation, including its intended application, target market, and current stage of development. Responses should include well-supported rationale for the readiness levels selected below.

What is the Technology Readiness Level (TRL) of the proposed project?(Required)

If applicable, what is the Manufacturing Readiness Level (MRL) of the proposed project?

MIT CFRL Level

Had this hidden in the last form, does it help to have this at all?

If applicable, what is the regulatory pathway for the product or service?

Provide a clear description of the federal regulatory pathway for the device, drug, diagnostic, therapeutic, digital tool, etc.

Commercialization Progress

Provide evidence of demonstrated progress toward commercialization of the SBIR/STTR-funded product or service.

Private Investments Raised to Date

Provide a list of private investment raised to date (e.g., angel, venture capital, or strategic investment).

Type of Investment

Amount ($)

Commercialization Narrative(Required)

• Evidence of demonstrated progress toward commercialization of the SBIR/STTR-funded product or service. • A description of current Phase III commercialization goals and strategy, including the planned pathway to market.

Phase I Awardee Supporting Documentation

To show commercial readiness and momentum toward Phase III, we strongly encourage documentation (letters, etc.) from customers, investors, strategic partners to validate the assertions. Maximum File Size: 2MB Maximum Number of Uploads: 10 Accepted File Type: PDF

Drop files here or

Accepted file types: pdf, Max. file size: 2 MB, Max. files: 10.

4.3 Proposed Phase III Commercialization Project

The proposal will include the following sections in this sequence: 1) Commercialization Gap; 2) Proposed Activities and Tasks; 3) Milestones and Timelines; 4) Measurable Outcomes and Success Metrics; 5) Phase III Acceleration Strategy; and 6) Expected Impact. As a reminder, you may save and continue at any time.

1. Commercialization Gap(Required)

Identify the specific commercialization gap this funding will address .• Describe the current barrier preventing transition to Phase III (e.g., regulatory milestone, pilot validation, manufacturing scale-up, federal procurement positioning, etc.). • Explain why this gap is critical at this stage. • Describe consequences if the gap is not addressed.

2a. Proposed Activities and Tasks

For each activity, including: • Activity Title • Description of Work • Responsible Party (external vendors) • Deliverables Applicants are strongly encouraged to use a table format to clearly present each Activity, including its Description, Responsible Party, Deliverable, and Anticipated Outcomes at both 6- and 12-month intervals.

2b. Proposed Activities and Tasks(Required)

Activity Title

Description of Work

Responsible Party

Deliverables

3aMilestones and Timeline

Provide a clear timeline for completion (typically within 4-6 months). Explain how milestones logically progress toward addressing the stated commercialization gap.

3b. Milestones and Timeline(Required)

Provide a clear timeline for completion (typically within 4-6 months). Explain how milestones logically progress toward addressing the stated commercialization gap.

Description of Milestone

Start Date (mm/dd/yyyy)

Completion Date (mm/dd/yyyy)

4. Measurable Outcomes and Success Metrics(Required)

Define how success will be measured. Metrics must be:
1) Specific
2) Measurable
3) Achievable
4) Relevant and
5) Time-bound Include quantitative metrics whenever possible, such as: • Customer pilots secured • Regulatory submissions completed • Manufacturing readiness level increased • Contracts submitted or awarded • Revenue generated • Investment secured • TRL/MRL advancement

5. Phase III Acceleration Strategy(Required)

Explain how the proposed activities will accelerate progress toward Phase III objectives, including: • Federal sole-source contracting • Commercial sales • Strategic partnerships • Private investment Describe how this funding shortens time-to-market or reduces commercialization risk.

6. Expected Impact(Required)

• What will be materially different as a result of funding after 6 and 12 months. • The next logical commercialization step after completion of this project

Final Steps

Consent

By requesting business management and technical assistance services from MNSBIR, Inc., I understand that all consultants, counselors, and personnel assigned to assist me will treat all information and data received in complete confidence. I acknowledge that this is a management and technical assistance service, and not legal, tax, or financial advice. In consideration of receiving this support, I hereby waive any and all claims against MNSBIR, Inc., its affiliates, consultants, counselors, and personnel arising from or related to this assistance. I agree to cooperate if selected to participate in surveys or evaluations designed to assess the effectiveness of these services. I further understand that any consultant working with me has agreed not to recommend goods or services from sources in which they have a financial interest, nor accept fees or commissions resulting from this relationship. By signing my full name below, I acknowledge that I have read, understood, and accepted the terms of this agreement.

I accept the agreement above.

Your Signature(Required)

Insert any number (Human Check)

Please leave this box checked if you already receive emails.

I consent to receive email communications from MNSBIR, Inc.

Programs

About Our Programs
Catalyst Program
— Catalyst Readiness Tool
— Catalyst Program Application
— Intent to Apply
— Post Proposal Submission Survey
Transition Program
Commercialization Institute
Other Ecosystem Programs

About Us

About MNSBIR
Our Team
Board of Directors
Advocacy

Quick Links

About SBIR/STTR Funding
About Our Programs
Overview & Funding Resource Guide
Catalyst Readiness Tool
Success Stories

News

Footer Post List

Silicon Tundra? Tech startups eye testing autonomous vehicles in northern Minnesota

Silicon Tundra? Tech startups eye testing autonomous vehicles in northern Minnesota

February 13, 2026

Vyriad, startup from Mayo doctors, raises $25M for trial of multiple myeloma treatment

Vyriad, startup from Mayo doctors, raises $25M for trial of multiple myeloma treatment

January 27, 2026

Collaboration.Ai Acquires innosabi

Collaboration.Ai Acquires innosabi

January 23, 2026

Stay updated on events, initiatives, and funding opportunities!

Fill out the fields below and hit “enter” on your keyboard or the “go” button on your phone to complete your sign-up.

* indicates required

Email Address *

First Name *

Last Name *

Funded Companies

Abbe Vision, Inc. | Ability Interactive LLC | Aclaris Medical, LLC | Adapt Design Works | Adialante, LLC | Advanced Medical Electronics Corporation | Advanced Research Corporation | AdvancedCPR Solutions LLC | Adventium Enterprises, LLC (a Galois company) | Aero Systems Engineering, Inc. | Agitated Solutions Inc. | Agnitron Technology, Inc | Algenta Technologies LLC | Anno.Ai, Inc. | Aplos Medical | Applied Membrane Technology, Inc. | Applied Universal Dynamics, Corp. | Area 10 Labs | Architecture Technology, Inc. | Ascan LLC | Aster Labs, Inc | Astral Technology Unlimited, Inc. | Astrin Biosciences, Inc. | Audiology, Inc | Aveka, Inc. | Avisure International Inc. | Ballistic Recovery Systems, Inc. | Benson Medical Instruments Company | Berd LLC | Bettertime Co | Betula Extractives, LLC. | BH Electronics, Inc. | Bischoff Holdings, Inc. | Blue Sky Designs Inc | Cambridge Technologies LLC | Canomiks, Inc. | CD3, General Benefit Corporation | Cerovations, LLC | Champaign Imaging LLC | Chromatic 3D Materials Inc. | Cirrus Design | Claritytek, Inc. | Claros Technologies Inc. | Clarus Medical Systems | Clean Plus, Inc. | Glimpse Diagnostics (Formerly Cohi Group, LLC) | Collaboration.Ai, LLC | Conway Medical LLC | Coravie Medical, Inc. | Cortec Corp. | Darcy Solutions Inc. | Daynamica, Inc. | Designs By Natural Processes, Inc. | Diagnostic Biosensors LLC | Diffraction International | Dynation LLC | Echochem Research, Inc. | Eden Medical, Inc. | Elements Endoscopy Inc | Embro Corporation | Envoy Medical Corporation | Excorp Medical, Inc. | Exergi Predictive LLC | Factory Twin | Femtofluidics Incorporated | First Light Observatory Systems LLC | Fistula Solution Corporation | Fluidyne Engineering Corp. (Phoenix Solutions) | Flywheel Exchange, LLC | Fybraworks Foods Inc. | General Probiotics Inc | Genesegues Inc. | Glimpse Diagnostics | Gogyup Inc | Grey Street Systems LLC | Habitaware, Inc. | Healthcare Interactive, Inc. | Hearing Components, Inc. | Hennepin Life Sciences | Humanetics Corporation | Imacular Regeneration LLC | Imanis Life Sciences, LLC | Imbio, LLC | Imricor Medical Systems, Inc. | Industron Technical Services Inc. | Inkit, Inc. | Innocent Classroom | Innotronics LLC | Innovative Design Labs Inc. | Innovative Research, Inc. | Innovative Surface Technologies, Inc | Isola Therapeutics, Inc. | Itasca Consulting Group, Inc. | Kinetic Protection | Knightronix, Inc. | Kommodo Therapeutics LLC | Koronis Biomedical Technologies Corp. | Lasx Industries, Inc. | Leonine Technologies Inc | Life Services L.L.C. | Lifengine Animal Health Laboratories Incorporated | Lightwave Photonics, Inc. | Lite Run, Inc. | LKT Laboratories, Inc. | Loon Medical, LLC | Luminary Therapeutics, Inc. | Marani Health, Inc. | Marpam Pharma LLC | Maxwell Labs | Medical Innovations International, Inc. | Mei Research, Ltd | Metselex, Incorporated | Mineralogic LLC | Minnesota Healthsolutions Corporation | Minnesota Wire | Moai Technologies, LLC | Momease Solutions, Inc. | MSP Corporation | Myogenica | Myriel, Inc. | Nanocopoeia Inc. | Nanodropper, Inc. | Natural Process Design Inc | Nested Knowledge, Inc. | Neuro Devices, Inc. | Neurotype Inc. | Neurovasx, Inc. | New Wave Design Verification LLC | NexGen Cancer Detection, LLC | Nextgen RF Design, Inc. | Nightware Incorporated | Nonin Medical, Inc. | Northern Technologies International Corporation | Novoclade, Inc. | Nuborn Medical, Inc. | Nucleic Sensing Systems, LLC | NVE Corp. | Objective Biotechnology | Osemi Inc. | Pavaj Vascular Corporation | Phenomix Sciences LLC | Photonic Pharma LLC | Phygen/Phygen Coatings, Inc. | Physics Innovations, Inc. | Piraeus Medical, Inc. | Product Development Associates, Inc. | Promet International, Inc | Pro-West And Associates | Pure Biomass Inc. | Pure BioX | Qen Labs | Qrona Technologies LLC | Quality Research, Development & Consulting, Inc. | Quench Medical Inc. | Radwave Technologies Inc. | Recombinetics, Inc. | Reconrobotics | Rehabnetics Medical LLC | Remastered Sleep LLC | Remooble | Riptide Therapeutics LLC | Ross-Hime Designs Inc | Rowbot Systems, LLC | Rozin Security Consulting LLC | RxFunction Inc. | Sartec Corporation | Sasya Inc | Semaphore Scientific, Inc. | Sersense Inc. | Shape Medical Systems, Inc. | Shock Transients, Inc. | Silk Technologies, Ltd. | Simulution, Inc. | Smart Information Flow Technologies, LLC | Speechgear, Inc. | Spinethera, Inc. | Spooky Action | Subc, Inc. | Superior Nano, LLC | Surmodics, Inc. (NASDAQ: SRDX) | SVT Associates, Incorporated | Synaptic Health LLC | T3 Scientific LLC | Tfwireless, Inc. | The Restful Jaw Co LLC | Third Wave Systems, Inc. | TJB Medical, Inc. | TLC Millimeter Wave Products | Top-Vu Technology, Inc. | TREKKA Therapeutics | Trusted Semiconductor Solutions Inc. | TSI Inc. | Unlabel Innovation LLC | UR Turn, SBC | Verde Environmental Technologies, Inc. | Vergent Bioscience, Inc. | Vigilant Diagnostics LLC | Virtusaero LLC | Vivaquant, Inc. | Voiceit Technologies | Vyriad, Inc. | Walker Reading Technologies Inc | Weathervane Labs, LLC | Wincs International, LLC | Xanthoshealth LLC | Xetex, Inc. | Zirchrom Separations, Inc.

Website in collaboration with junebird creative LLC.

MNSBIR, Inc. is an IRS 501 (c) (3) organization funded in part through a Federal and State Technology Partnership Cooperative Agreement with the U.S. Small Business Administration, a grant from the Minnesota Department of Employment and Economic Development, and cash contributions from the University of Minnesota, Technology Commercialization Office and the Venture Center, and Carlson School of Management, Holmes Center for Entrepreneurship.
MNSBIR, Inc. is a 501(c)(3) organization; Federal EIN: 32-0685806.

Type your search here

Search for ...